Effective targeting of E2F1 transcription factor via siRNA gene electrotransfer in HT-29 colorectal carcinoma xenografts
Open Access
- 25 April 2025
- journal article
- Published by Elsevier in Bioelectrochemistry
- Vol. 165, 108994
Abstract
No abstract availableKeywords
Funding Information
- Government of Italy Ministry of Foreign Affairs and International Cooperation (VN21GR01)
- Slovenian Research and Innovation Agency (P3-0003)
This publication has 45 references indexed in Scilit:
- Stereotactic Percutaneous Electrochemotherapy as Primary Approach for Unresectable Large HCC at the Hepatic HilumCardioVascular and Interventional Radiology, 2021
- Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019)European Journal of Cancer, 2020
- Intraoperative electrochemotherapy of colorectal liver metastases: A prospective phase II studyEuropean Journal of Surgical Oncology, 2020
- Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patientsAnnals of Oncology, 2020
- Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot studyEuropean Journal of Surgical Oncology, 2018
- Gene electrotransfer into skin using noninvasive multi-electrode array for vaccination and wound healingBioelectrochemistry, 2017
- E2F1 transcription factor and its impact on growth factor and cytokine signalingCytokine & Growth Factor Reviews, 2016
- Imaging of Electrotransferred siRNA2016
- Advances in RNA Sensing by the Immune System: Separation of siRNA Unwanted Effects from RNA Interference2010
- Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) studyEuropean Journal of Cancer Supplements, 2006